Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGIN

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Revealed
India's Third Giant Leap

This Could be One of the Biggest Opportunities for Investors




Important: We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
By submitting your email address, you also sign up for Profit Hunter, a daily newsletter from Equitymaster
covering exciting investing ideas and opportunities in India.

AD

Weak Start to the Week
Mon, 7 Dec Closing

Indian equity markets closed weak for the fourth straight session as selling activity picked up as the day progressed. The BSE-Sensex finished lower by 108 points while the NSE-Nifty fell 17 points amidst profit booking. The FMCG sector was the worst performing sector with its representative index plunging by nearly 2.5%. While the BSE Mid Cap stocks fell nearly 0.1%, BSE Small Cap stocks closed higher by 0.2%.

Asian markets finished mixed as of the most recent closing prices. The Nikkei 225 gained 0.99% and the Shanghai Composite rose 0.34%. The Hang Seng lost 0.15%. European markets are broadly higher today with shares in Germany leading the region. The DAX is up 1.68% while France's CAC 40 is up 1.36% and London's FTSE 100 is up 0.55%. The rupee was trading at 66.63 against the US$ in the afternoon session.

According to a leading financial daily, Siemens has won a crucial order approximately worth Rs 3.77 billion from Indian Railways' Diesel Locomotive Works (DLW), Varanasi. The scope of work for the project involves supply of 1,890 Traction Motors for 4,500 HP Diesel Electric Locomotives. The Traction Motors will be produced at Kalwa Factory of Siemens.

Siemens had reported a 49.8% plunge in standalone net profit at Rs 2.19 billion for the quarter ended September 30, 2015. The stock closed higher by 1.3% today.

2015 has been a disappointing year for the Indian engineering industry. Majority of the stocks from the space have underperformed, barring a few exceptions. The broader issue surrounding the sector is that of the economic recovery not panning out as anticipated and the investment cycle not picking up with stalled projects yet to kick off in a big way. In our recent articles of '5 Minute Wrap Up', we outlined the engineering stocks which have underperformed the Sensex and what is expected of engineering sector going forward (Subscription Required).

According to a leading financial daily, Dr. Reddy's Laboratories has signed a Memorandum of Understanding (MoU) with The Life Sciences Sector Skill Development Council (LSSSDC) and Vishnu Institute of Pharmaceutical Education and Research (VIPER). The MoU is aimed at fostering market research collaboration between LSSSDC and industry partners that in turn will help align educational courses to industry requirements. The MoU will also collaborate to create pharmaceutical, biotechnology and clinical research occupation standards, as well as establish a competency matrix for job roles in the pharmaceutical sector.

Reportedly, the partnership will also help strengthen the skilled labor pool and create standards for certification and accreditation, as per the requirements of the life sciences sector. Pharma stocks finished on a mixed note, with Sun Pharma and Dishman Pharma leading the gains.

As per available data, the global biosimilar market (also known as follow-on biologics) is expected to reach US$35 billion in 2020, up from US$1.13 billion in 2013. This means this market is expected to grow at a compound annual growth rate of 60% from 2014-2020. Biologics use has been increasing rapidly. In our recent edition of 'The 5 Minute Wrap Up Premium', we highlight the companies that are making a stride in biopharmaceutical sector (Subscription Required).

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

View all commentaries | Archives

Read the latest Market Commentary


Equitymaster requests your view! Post a comment on "Weak Start to the Week". Click here!

  
ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
TRENDING TOPICS
FREE NEWSLETTERS
EQUITYMASTER SUPPORTS
  • HelpYourNGO
  • You Tube
  • Linkedin
  • Twitter
  • Telegram
  • Google Play

Copyright © Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited).

Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap

Phone +91-9136015013

Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst)
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Email: info@equitymaster.com. Website: www.equitymaster.com.
CIN:U74999MH2007PTC175407

Name of the Compliance & Grievance Officer: Ms Sonal Ramachandran
Telephone: +91-22-61434003 | Email: compliance@equitymaster.com

LEGAL DISCLAIMER:
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.